Cardiovascular diseases may play a negative role in the prognosis of ALS

Background : Only a few studies considered the role of comorbidities on ALS prognosis and provided conflicting results. Methods : our multicenter, retrospective study included patients diagnosed from 1/1/2009 to 31/12/2013 in 13 Referral Centers for ALS located in 10 Italian Regions. Caring neurologists collected a detailed phenotypic profile and follow-up data until death into an electronic database. Comorbidities at diagnosis were recorded by main categories and single medical diagnosis, with the aim of investigating their role on ALS prognosis. Results : 2354 incident cases were collected, with a median survival time from onset to death/tracheostomy of 43 months. According to univariate analysis, together with well known clinical prognostic factors (age at onset, diagnostic delay, site of onset, phenotype, Revised El Escorial Criteria (R-EEC) and BMI at diagnosis), the presence of dementia, hypertension, heart diseases, chronic obstructive pulmonary disease, haematological and psychiatric diseases were associated with worse survival. In multivariate analysis age at onset, diagnostic delay, phenotypes, BMI at diagnosis, R-EEC, dementia, hypertension, heart diseases (atrial fibrillation and heart failure), and haematological diseases (disorders of thrombosis and haemostasis) were independent prognostic factors of survival in ALS. Conclusions : our large, multicenter study demonstrated that, together with the known clinical prognostic factors on ALS survival, hypertension and heart diseases (i.e. atrial fibrillation and heart failure) as well as haematological diseases are independently associated to a shorter

[1]  M. Rich,et al.  Epidemiology, Pathophysiology, and Prognosis of Heart Failure in Older Adults. , 2017, Heart failure clinics.

[2]  A. Chiò,et al.  Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study , 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[3]  Maureen E. Czick,et al.  Atrial Fibrillation: The Science behind Its Defiance , 2016, Aging and disease.

[4]  Cassie S. Mitchell,et al.  Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom? , 2016, Front. Neurol..

[5]  Cassie S. Mitchell,et al.  Antecedent Disease Is Less Prevalent in Amyotrophic Lateral Sclerosis , 2015, Neurodegenerative Diseases.

[6]  Frans Nollet,et al.  Prognostic factors for the course of functional status of patients with ALS: a systematic review , 2014, Journal of Neurology.

[7]  H. Mitsumoto,et al.  Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved? , 2014, The Lancet Neurology.

[8]  S. Parikh,et al.  Autonomic etiology of heart block in amyotrophic lateral sclerosis: a case report , 2014, Journal of Medical Case Reports.

[9]  Adriano Chiò,et al.  Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  S. Petri,et al.  Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis , 2013, European journal of neurology.

[11]  Richard D Riley,et al.  Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes , 2013, BMJ : British Medical Journal.

[12]  Philippe Amouyel,et al.  Modifying effect of arterial hypertension on amyotrophic lateral sclerosis , 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[13]  Marianna Cavinato,et al.  Autonomic dysfunction in the early stage of ALS with bulbar involvement , 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[14]  Timothy L Lash,et al.  The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients , 2011, BMC medical research methodology.

[15]  L. H. van den Berg,et al.  Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[16]  Adriano Chiò,et al.  The epidemiology and treatment of ALS: Focus on the heterogeneity of the disease and critical appraisal of therapeutic trials , 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[17]  E. Beghi,et al.  Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[18]  K. Shimada,et al.  Sympathetic disturbances increase risk of sudden cardiac arrest in sporadic ALS , 2007, Journal of the Neurological Sciences.

[19]  A. Chiò,et al.  Factors predicting survival in ALS: a multicenter Italian study , 2016, Journal of Neurology.